Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma
Chari, Ajai, Suvannasankha, Attaya, Fay, Joseph W., Arnulf, Bertrand, Kaufman, Jonathan L., Ifthikharuddin, Jainulabdeen J., Weiss, Brendan M., Krishnan, Amrita, Lentzsch, Suzanne, Comenzo, Raymond, Wang, Jianping, Nottage, Kerri, Chiu, Christopher, Khokhar, Nushmia Z., Ahmadi, Tahamtan, Lonial, Sagar
Published in Blood (24.08.2017)
Published in Blood (24.08.2017)
Get full text
Journal Article
Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group
Terpos, Evangelos, Zamagni, Elena, Lentzsch, Suzanne, Drake, Matthew T, García-Sanz, Ramón, Abildgaard, Niels, Ntanasis-Stathopoulos, Ioannis, Schjesvold, Fredrik, de la Rubia, Javier, Kyriakou, Charalampia, Hillengass, Jens, Zweegman, Sonja, Cavo, Michele, Moreau, Philippe, San-Miguel, Jesus, Dimopoulos, Meletios A, Munshi, Nikhil, Durie, Brian G M, Raje, Noopur
Published in The lancet oncology (01.03.2021)
Published in The lancet oncology (01.03.2021)
Get full text
Journal Article
Immunomodulatory Drugs (IMiDs) in Multiple Myeloma
Raza, Shahzad, Safyan, Rachael A, Lentzsch, Suzanne
Published in Current cancer drug targets (01.01.2017)
Published in Current cancer drug targets (01.01.2017)
Get more information
Journal Article
Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma
Shah, Jatin J., Stadtmauer, Edward A., Abonour, Rafat, Cohen, Adam D., Bensinger, William I., Gasparetto, Cristina, Kaufman, Jonathan L., Lentzsch, Suzanne, Vogl, Dan T., Gomes, Christina L., Pascucci, Natalia, Smith, David D., Orlowski, Robert Z., Durie, BrianG.M.
Published in Blood (12.11.2015)
Published in Blood (12.11.2015)
Get full text
Journal Article
International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma–Related Bone Disease
TERPOS, Evangelos, MORGAN, Gareth, REIMAN, Tony, JURCZYSZYN, Artur, MERLINI, Giampaolo, SPENCER, Andrew, LELEU, Xavier, CAVO, Michele, MUNSHI, Nikhil, VINCENT RAJKUMAR, S, DURIE, Brian G. M, ROODMAN, G. David, DIMOPOULOS, Meletios A, DRAKE, Matthew T, LENTZSCH, Suzanne, RAJE, Noopur, SEZER, Orhan, GARCIA-SANZ, Ramón, SHIMIZU, Kazuyuki, TURESSON, Ingemar
Published in Journal of clinical oncology (20.06.2013)
Published in Journal of clinical oncology (20.06.2013)
Get full text
Journal Article
The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma
Hammons, Lindsay, Szabo, Aniko, Janardan, Abhishek, Bhatlapenumarthi, Vineel, Annyapu, Evanka, Dhakal, Binod, Al Hadidi, Samer, Radhakrishnan, Sabarinath Venniyil, Narra, Ravi, Bhutani, Divaya, Thanendrarajan, Sharmilan, Janz, Siegfried, Zangari, Maurizio, Lentzsch, Suzanne, Van Rhee, Frits, Crescencio, Juan Carlos Rico, D'Souza, Anita, Chakraborty, Rajshekhar, Mohan, Meera, Schinke, Carolina
Published in Haematologica (Roma) (01.03.2024)
Published in Haematologica (Roma) (01.03.2024)
Get full text
Journal Article
The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone disease
Fu, Jing, Li, Shirong, Ma, Huihui, Yang, Jun, Pagnotti, Gabriel M., Brown, Lewis M., Weiss, Stephen J., Mapara, Markus Y., Lentzsch, Suzanne
Published in Nature communications (17.07.2023)
Published in Nature communications (17.07.2023)
Get full text
Journal Article
Targeting the GCK pathway: a novel and selective therapeutic strategy against RAS-mutated multiple myeloma
Li, Shirong, Fu, Jing, Yang, Jun, Ma, Huihui, Bhutani, Divaya, Mapara, Markus Y., Marcireau, Christophe, Lentzsch, Suzanne
Published in Blood (01.04.2021)
Published in Blood (01.04.2021)
Get full text
Journal Article
IFN-γR/STAT1 signaling in recipient hematopoietic antigen-presenting cells suppresses graft-versus-host disease
Lu, Caisheng, Ma, Huihui, Song, Liangsong, Wang, Hui, Wang, Lily, Li, Shirong, Lagana, Stephen M, Sepulveda, Antonia R, Hoebe, Kasper, Pan, Samuel S, Yang, Yong-Guang, Lentzsch, Suzanne, Mapara, Markus Y
Published in The Journal of clinical investigation (01.02.2023)
Published in The Journal of clinical investigation (01.02.2023)
Get full text
Journal Article
Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis
Premkumar, Vikram J., Lentzsch, Suzanne, Pan, Samuel, Bhutani, Divaya, Richter, Joshua, Jagannath, Sundar, Liedtke, Michaela, Jaccard, Arnaud, Wechalekar, Ashutosh D., Comenzo, Raymond, Sanchorawala, Vaishali, Royer, Bruno, Rosenzweig, Michael, Valent, Jason, Schönland, Stefan, Fonseca, Rafael, Wong, Sandy, Kapoor, Prashant
Published in Blood cancer journal (New York) (11.01.2021)
Published in Blood cancer journal (New York) (11.01.2021)
Get full text
Journal Article
Efficacy and safety of once weekly selinexor 40 mg versus 60 mg with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma
White, Darrell, Schiller, Gary J, Madan, Sumit, Lentzsch, Suzanne, Chubar, Evgeni, Lavi, Noa, Van Domelen, Dane R, Bentur, Ohad S, Baljevic, Muhamed
Published in Frontiers in oncology (17.05.2024)
Published in Frontiers in oncology (17.05.2024)
Get full text
Journal Article
Immunomodulatory drugs downregulate IKZF1 leading to expansion of hematopoietic progenitors with concomitant block of megakaryocytic maturation
Liu, Ailing, Li, Shirong, Donnenberg, Vera, Fu, Jing, Gollin, Susanne M, Ma, Huihui, Lu, Caisheng, Stolz, Donna B, Mapara, Markus Y, Monaghan, Sara A, Lentzsch, Suzanne
Published in Haematologica (Roma) (01.10.2018)
Published in Haematologica (Roma) (01.10.2018)
Get full text
Journal Article
Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee
Kumar, Shaji, Baizer, Lawrence, Callander, Natalie S., Giralt, Sergio A., Hillengass, Jens, Freidlin, Boris, Hoering, Antje, Richardson, Paul G., Schwartz, Elena I., Reiman, Anthony, Lentzsch, Suzanne, McCarthy, Philip L., Jagannath, Sundar, Yee, Andrew J., Little, Richard F., Raje, Noopur S.
Published in Blood cancer journal (New York) (29.06.2022)
Published in Blood cancer journal (New York) (29.06.2022)
Get full text
Journal Article
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Mohan, Meera, Monge, Jorge, Shah, Nishi, Luan, Danny, Forsberg, Mark, Bhatlapenumarthi, Vineel, Balev, Metodi, Patwari, Anannya, Cheruvalath, Heloise, Bhutani, Divaya, Thanendrarajan, Sharmilan, Dhakal, Binod, Zangari, Maurizio, Al-Hadidi, Samer, Cooper, Dennis, Lentzsch, Suzanne, van Rhee, Frits, D’Souza, Anita, Szabo, Aniko, Schinke, Carolina, Chakraborty, Rajshekhar
Published in Blood cancer journal (New York) (05.03.2024)
Published in Blood cancer journal (New York) (05.03.2024)
Get full text
Journal Article
A Phase 1 First in Human (FIH) Study of AMG 701, an Anti-B-Cell Maturation Antigen (BCMA) Half-Life Extended (HLE) BiTE® (bispecific T-cell engager) Molecule, in Relapsed/Refractory (RR) Multiple Myeloma (MM)
Harrison, Simon J, Minnema, Monique C., Lee, Hans C., Spencer, Andrew, Kapoor, Prashant, Madduri, Deepu, Larsen, Jeremy, Ailawadhi, Sikander, Kaufman, Jonathan L., Raab, Marc S., Hari, Parameswaran, Iida, Shinsuke, Vij, Ravi, Davies, Faith E., Lesley, Robin, Upreti, Vijay V., Yang, Zhao, Sharma, Anjali, Minella, Alex, Lentzsch, Suzanne
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article